NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Horizon Kinetics director Allison Nagelberg acquires shares worth $1,949

Published 11/18/2024, 10:14 AM
HKHC
-

In a recent transaction reported to the Securities and Exchange Commission, Allison Nagelberg, a director at Horizon Kinetics Holding Corp (NASDAQ:HKHC), acquired 50 shares of the company’s common stock. The shares were purchased at a price of $38.99 each, amounting to a total transaction value of $1,949. Following this purchase, Nagelberg holds a total of 250 shares directly. This acquisition reflects Nagelberg's continued investment in the company, which operates in the perfumes, cosmetics, and other toilet preparations industry.

InvestingPro Insights

Allison Nagelberg's recent purchase of Horizon Kinetics Holding Corp (NASDAQ:HKHC) shares aligns with several positive indicators highlighted by InvestingPro. The company's stock has shown strong performance, with InvestingPro data revealing a remarkable 58.16% price return over the past month and an even more impressive 68.48% return over the last three months. This upward trajectory suggests growing investor confidence in HKHC's prospects.

InvestingPro Tips point out that HKHC holds more cash than debt on its balance sheet, indicating a solid financial position. This financial stability is further underscored by the fact that the company's liquid assets exceed its short-term obligations. These factors may have contributed to Nagelberg's decision to increase her stake in the company.

It's worth noting that HKHC is trading at a high earnings multiple, with a P/E Ratio (Adjusted) of 484.79 for the last twelve months as of Q3 2024. This valuation suggests that investors have high growth expectations for the company, which operates in the dynamic perfumes, cosmetics, and other toilet preparations industry.

For investors seeking a more comprehensive analysis, InvestingPro offers 12 additional tips for HKHC, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.